Css LLC Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

Css LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $1.07 Million - $1.13 Million	7,400 New	7,400 $1.12 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $1.45 Million - $1.89 Million	-13,200 Reduced 28.21%	33,600 $3.98 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $149,595 - $222,719	-1,500 Reduced 3.11%	46,800 $6.45 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $4.77 Million - $6.71 Million	48,300 New	48,300 $6.71 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $1.22 Million - $1.75 Million	-19,100 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $1.24 Million - $1.88 Million	19,100 New	19,100 $1.64 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $2.83 Million - $3.73 Million	-47,900 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $417,744 - $1.07 Million	14,400 Added 42.99%	47,900 $3.5 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $921,585 - $1.92 Million	33,500 New	33,500 $1.14 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.